Topic: Price Transparency
Industry groups are weighing in on CMS’ final Inpatient Prospective Payment System rule, and they see both pros and cons in the regulation.
The Maryland Health Care Commission expanded its price transparency initiative with hospital cost comparison tools for consumers.
Variability in specialty drug coverage among commercial payers raises questions about the rationale behind coverage decisions.
Health policy experts blamed hospital consolidation and a lack of price transparency as some of the key drivers of ballooning healthcare costs.
Making good on its promise, CMS unveiled its inaugural Medicaid/CHIP scorecard but dodged on whether it'll punish states that receive poor scores.
Sutter Health is calling for the state's case against it for anticompetitive practices to be dismissed.
HHS Secretary Alex Azar confirmed that President Trump's long-awaited speech on the administration's plan to lower drug prices is slated for Friday.
The latest jobs report says healthcare added 24,000 jobs in April, with hospitals contributing more than 8,000 of them.
With its scale, HHS can either help or hinder efforts to make it easier for patients to find prices in healthcare, said HHS Secretary Alex Azar.